US EditionReceipt of a significant order by a company affiliated with Selvita S.A.
Summary by Selvita
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Receipt of a significant order by a company affiliated with Selvita S.A.
The Management Board of Selvita S.A., with its registered office in Kraków (the “Issuer” or the “Company”), hereby informs that on June 26, 2025, the Issuer’s subsidiary – Selvita Inc. – received two orders for the provision of services (the “Orders”) from a biotechnology company headquartered in the United States (the “Client”). The Orders pertain to the continuation of work under the Client’s integrated drug discovery program, performed under …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
